Last reviewed · How we verify

NCT02135913

Roles of Vitamin D and HDL in Obese Children

Completed NA Last updated 2 May 2017
What this trial tests

NA trial testing Vitamin D in Obese in 1 participant. Completed in 26 April 2017.

Timeline
1 January 2016
Primary endpoint
26 April 2017
26 April 2017

Quick facts

Lead sponsorXiang-An Li
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment1
Start date1 January 2016
Primary completion26 April 2017
Estimated completion26 April 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Xiang-An Li

Who can join

Adults 5 to 18, any sex, with Obese or Vitamin D Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a pilot study to determine the association between Vitamin D deficiency in obese children and low high density lipoprotein (HDL) and dysfunctional HDL.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Proteomic and functional analysis of HDL subclasses in humans and rats: a proof-of-concept study.
    Huang C, Zhang J, Huang J, Li H, et al · · 2023 · cited 8× · PMID 37386457 · DOI 10.1186/s12944-023-01829-9

Verify or expand the search:

Other trials of Vitamin D

Trials testing the same drug.

Other recruiting trials for Obese

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02135913.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing